Taking the helm of EFPIA, Viehbacher says R&D and innovation are the keys to rescuing Europe from its economic slump, but more harmonization across the pharmaceutical sector will be needed too.
To read the full, original article click on this link: U.S. Provides Better Incubation Environment For Biotech Than Europe, Says Sanofi’s Viehbacher :: “The Pink Sheet” :: Elsevier Business Intelligence